Enteral Feeding Formulas Market is expected to reach US$ 11,726.37 Million by 2028


PRESS RELEASE BY The Insight Partners 05 Sep 2022

Share this press on


Standard Enteral Formula Types accounted the Largest Share in Enteral Feeding Formulas Market

According to our latest market study on "Enteral Feeding Formulas Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, Form, Age Group, Distribution Channel, and Geography," the market is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2022 to 2028.

Enteral Feeding Formulas Market Forecast


Enteral Feeding Formulas Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Download Free Sample

Enteral Feeding Formulas Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: by Type (Standard Formulas, Peptide Formulas, Specialized Formulas, and Others), Application (Respiratory Disorders, Cancer, Gastroenterology Disorders, Diabetes, Liver/Kidney Disease, Neurology, Post COVID-19, and Others), Form (Powder, Liquid, and Semi-Solid), Age Group [(Children (Till 18 Years) and Adult (18+ Years)], Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Source: The Insight Partners Analysis

According to “Dieticians On Demand Case Study,” standard enteral formulas provide 10–45% of energy from fat sources, including canola oil, corn oil, soy lecithin, safflower oil, and medium-chained triglycerides. Diabetisource AC manufactured by Nestle Health Sciences is composed of soy protein and gluten-free in nature. It can be used by lactose intolerant consumers. The product contains low amount of carbohydrates and fiber. Also, Fibersource HN manufactured by Nestle Health Sciences consists of milk and soy protein, as well as a low amount of protein and fiber.

Based on type, the enteral feeding formulas market is segmented into standard formulas, peptide formulas, specialized formulas, and others. The standard formulas segment held the largest market share in 2021. The same segment is expected to continue its dominance during the forecast period. On the other hand, the market for the specialized formulas segment is expected to witness the significant growth during the forecast period. Specialized formulas are used in the treatment of specific diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), wound healing, and chronic kidney disease (on and off dialysis).

Based on application, the enteral feeding formulas market is segmented into respiratory disorders, cancer, gastroenterology disorders, diabetes, liver/kidney disease, neurology, post COVID-19, and others. The respiratory disorders segment held the largest market share in 2021. On the other hand, the market for the cancer segment is expected to witness the rapid growth during the forecast period.

Based on form, the enteral feeding formulas market is segmented into powder, liquid, and semi-solid. The semi-solid segment captured the largest market share in 2021. Semi-solid nutrients can be directly delivered via a feeding tube/via syringe. Semi-solid nutrients are used as a nutritional management formula designed to prevent gastrointestinal complications by increasing the viscosity of the nutrient material injected via tube. In recent years, semi-solid nutrient formulations with a higher viscosity than liquid formulas have been reported to reduce gastroesophageal reflux (GER) in patients who have undergone percutaneous endoscopic gastrostomy. Also, they significantly decrease the dwell time in the stomach in adult patients. The semi-solid enteral formula (PG Soft EJ) is infused via the nasogastric tube (16Fr) or percutaneous endoscopic gastrostomy (PEG) tube (20Fr). The International Journal of Clinical Medicine investigated the benefits of semi-solid enteral formula. Its results show that in the treatment of aspiration pneumonia and diarrhea, changing liquid enteral formula to semi-solid enteral formula frequently shows improvement.

Based on age group, the enteral feeding formulas market is bifurcated into adult (18+ years) and children (till 18 years). The adult (18+ years) segment held a larger market share in 2021 and is expected to continue its dominance during the forecast period. On the other hand, the children (till 18 years) segment is expected to witness a higher CAGR during the forecast period.

Based on distribution channel, the enteral feeding formulas market is segmented into hospital pharmacies, retail stores, and others. The hospital pharmacies segment captured the largest market share in 2021 and is expected to continue its dominance over the forecast period.

Abbott; Nestle Health Science; Magnacal?Renal; UNILEVER; Danone; Kate Farms; Nutricia; Smartfish AS; Fresenius Kabi AG; and Hormel Foods Corporation are among the key enteral feeding formulas market players profiled during the study. Several other major companies were studied and analyzed during this research study to get a holistic view of the market and its ecosystem.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure
-->